<DOC>
	<DOC>NCT01189604</DOC>
	<brief_summary>Phase IIB study to find the optimal dose rate range of propofol to maintain minimal-to-moderate sedation for diagnostic gastrointestinal endoscopy and gastrointestinal polypectomy.</brief_summary>
	<brief_title>Dose Rate Range Finding Study of Propofol for minimal-to Moderate Sedation on Upper &amp; Lower Endoscopic Tests</brief_title>
	<detailed_description />
	<mesh_term>Propofol</mesh_term>
	<criteria>Male or female (females of child bearing potential to confirm not pregnant via test or contraception) Be undergoing a nonemergent esophagogastroduodenoscopy (EGD) or colonoscopy, including polypectomy that shall be completed within 1 hour American Society of Anesthesiologists (ASA) grade III, IV V and VI Baseline oxygen saturation&lt;90% (room air) Body Mass Index (BMI) &gt;=35</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>propofol endoscopy sedation</keyword>
</DOC>